Logo
x

Search

Subscribe Now

enters

Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease

Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease

  • October 22, 2021
Incyte Enters into a Supply Agreement with Specialised Therapeutics to Launch Tafasitamab and Pemigatinib in Australia and Other Countries

Incyte Enters into a Supply Agreement with Specialised Therapeutics to Launch Tafasitamab and Pemigatinib in Australia and Other C...

  • October 22, 2021
Janssen Enters into a License and Collaboration Agreement with F-star to Develop and Commercialize Multiple Bispecific Antibody Therapeutics

Janssen Enters into a License and Collaboration Agreement with F-star to Develop and Commercialize Multiple Bispecific Antibody Th...

  • October 21, 2021
Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for Antibody-Drug Conjugate Candidates

Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for Antibody-Drug Conjugat...

  • October 21, 2021
SpringWorks Enters into an Exclusive WW License Agreement with Academic Institutions to Advance Portfolio of Mutation-Selective EGFR Inhibitors

SpringWorks Enters into an Exclusive WW License Agreement with Academic Institutions to Advance Portfolio of Mutation-Selective EG...

  • October 20, 2021
Lipocine Enters into an Exclusive License Agreement with Antares to Commercialize Tlando in the US

Lipocine Enters into an Exclusive License Agreement with Antares to Commercialize Tlando in the US

  • October 19, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.